<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Pharmacol Toxicol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Pharmacol Toxicol</journal-id>
      <journal-title-group>
        <journal-title>BMC Pharmacology &amp; Toxicology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2050-6511</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23347670</article-id>
      <article-id pub-id-type="pmc">3566980</article-id>
      <article-id pub-id-type="publisher-id">2050-6511-14-8</article-id>
      <article-id pub-id-type="doi">10.1186/2050-6511-14-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" id="A1">
          <name>
            <surname>Lariccia</surname>
            <given-names>Vincenzo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>v.lariccia@univpm.it</email>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" id="A2">
          <name>
            <surname>Moraca</surname>
            <given-names>Alessandra</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>a.moraca@ospedaliriuniti.marche.it</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Marini</surname>
            <given-names>Marco</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>med.marini@tiscali.it</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Nasti</surname>
            <given-names>Annamaria Assunta</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>a.a.nasti@univpm.it</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Battistoni</surname>
            <given-names>Ilaria</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>i.battistoni@alice.it</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A6">
          <name>
            <surname>Amoroso</surname>
            <given-names>Salvatore</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>s.amoroso@univpm.it</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Perna</surname>
            <given-names>Gian Piero</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>perna54@yahoo.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of &#x201C;Biomedical Sciences and Public Health, University &#x201C;Politecnica delle Marche&#x201D;, Ancona, Italy</aff>
      <aff id="I2"><label>2</label>Department of Cardiology, Azienda Ospedaliero-Universitaria &#x201C;Ospedali Riuniti di Ancona&#x201D;, Ancona, Italy</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <volume>14</volume>
      <fpage>8</fpage>
      <lpage>8</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2013 Lariccia et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Lariccia et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/2050-6511/14/8"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Drugs not commonly considered to be cardioactive agents may cause prolongation of the QT interval with resultant torsades de pointes and ventricular fibrillation. This form of drug toxicity often causes cardiac arrest or sudden death.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>After accidental ingestion of tosylchloramide a caucasian 77-year-old woman, with a family history of cardiovascular disease and hypertension, was admitted to the intensive care unit following episodes of torsades de pointes with a prolonged QT/QTc interval (640/542 ms). The patient received an implantable cardioverter-defibrillator, was discharged from the hospital with normal QT/QTc interval and did not experience additional ventricular arrhythmias during one year of follow-up.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This is the first report concerning an unusual case of torsades de pointes after accidental intoxication by ingestion of tosylchloramide. The pronounced impact of the oxidyzing agent tosylchloramide on the activity of some of the ion channels regulating the QT interval was identified as a probable cause of the arrhythmia.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Tosylchloramide</kwd>
        <kwd>Acute intoxication</kwd>
        <kwd>Arrhythmia</kwd>
        <kwd>Ventricular fibrillation</kwd>
        <kwd>Ion channels</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Because of its high activity against fungi and bacteria, tosylchloramide is a widely used disinfectant agent for common applications such household cleaning and swimming pool disinfection. Many case reports describing tosylchloramide intoxication have been already published in the past showing that the chronic exposure to this compound may cause hypersensitivity reactions, such as asthma [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>], conjunctivitis [<xref ref-type="bibr" rid="B3">3</xref>], whereas toxic pneumonitis [<xref ref-type="bibr" rid="B4">4</xref>], cardiovascular collapse and myocardial damage may occur in acutely intoxicated patients [<xref ref-type="bibr" rid="B5">5</xref>]. Here we report the first case of a severe arrhythmia developed in the context of acute oral intoxication with tosylchloramide.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 77-year-old woman presenting shoulder girdle pain was admitted to our hospital with suspected coronary syndrome. She had a history of hypertension; treated since 5 years with Perindopril (5 mg once daily) and a family history of cardiovascular disease. Few hours after the admission at the Emergency Room (ER) the patient experienced a cardiac arrest due to a &#x201C;Torsade de Pointes&#x201D; (TdP) degenerated into ventricular fibrillation which required DC shock (200 J), as documented by electrocardiogram (ECG) (Figure <xref ref-type="fig" rid="F1">1</xref>). After specific questioning for drug intake, the patient revealed She had accidentally (non-intentionally) ingested an entire sachet of Euclorina (containing 2.5 g of tosylchloramide) between 5 and 6 hours before TdP.
</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>TDP with fast degeneration into Ventricular Fibrillation.</bold> The ECG-strip pre-TDP (Figure<xref ref-type="fig" rid="F1">1</xref>A) shows a QT interval of 640 msec (QTc is 542 msec).</p>
        </caption>
        <graphic xlink:href="2050-6511-14-8-1"/>
      </fig>
      <p>Surface ECG on admission in ER showed sinus rhythm with pre-existing left bundle branch block (LBBB). Serum potassium was in slightly lower normal range (3.3 mEq/l, before 3.8 mEq/l), while other haematological parameters were in their respective reference intervals (data not shown). On admission to the cardiology Intensive Care Unit (ICU) the ECG disclosed sinus bradycardia (55 bpm) with significant alteration in the QT interval (QT/QTc&#x2009;=&#x2009;640/543 msec; Figure <xref ref-type="fig" rid="F2">2</xref>) that was significantly prolonged over a 24-hour period. Thereafter the patient underwent an echocardiography that revealed concentric left ventricle hypertrophy with a mild reduction in global systolic function (LVEF&#x2009;=&#x2009;50%) due to LBBB-induced dyssynergy of the interventricular anterior septum wall.
</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>ECG at the admission to ICU shows a LBBB with a prolonged QT/QTc interval (640&#x2013;542 msec).</p>
        </caption>
        <graphic xlink:href="2050-6511-14-8-2"/>
      </fig>
      <p>The middle left anterior descending coronary artery (LAD) had a non-significant stenosis (&lt; 50%) as revealed by coronary angiography and IVUS control (Figure <xref ref-type="fig" rid="F3">3</xref>). A not significant stenosis was detected in a non-dominant right coronary artery (Figure <xref ref-type="fig" rid="F3">3</xref>). According to the criteria defined in Thygesen et al. [<xref ref-type="bibr" rid="B6">6</xref>], myocardial infarction was excluded for the following reasons: a) no symptoms or electrocardiographic changes were detected; b) the peak CK-MB level was 8.1 ng/ml (the normal reference value in our laboratory is &lt; 5 ng/ml) only after 6 h from DC shock, and normalized (3.2 ng/ml) within the following 6 h; c) the peak Troponin I level was 0.32 ng/ml (the normal reference value in our laboratory is &lt; 0.08 ng/ml) 6 h after DC shock, and normalized (0.06 ng/ml) 6 h later. No signs of liver or kidney derangement were observed (data not shown).
</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Coronary Angiography.</bold> No significant CAD is detected in right cororary artery. The middle left anterior descending coronary artery had a non-significant stenosis (&lt; 50%), as confirmed by IVUS control.</p>
        </caption>
        <graphic xlink:href="2050-6511-14-8-3"/>
      </fig>
      <p>The patient was discharged 7 days after admission, following the placement of an implantable cardioverter-defibrillator (ICD); the ECG at discharge showed a LBBB with a normal QT interval (QT/QTc&#x2009;=&#x2009;400/430 msec; Figure <xref ref-type="fig" rid="F4">4</xref>). After 12 and 24 months of follow-up She has been clinically stable, no shock detected at ICD registration and her QT interval was normal (Figure <xref ref-type="fig" rid="F5">5</xref>).
</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>ECG at hospital discharge.</bold> QT interval measures 400 msec, the QTc interval 430 msec.</p>
        </caption>
        <graphic xlink:href="2050-6511-14-8-4"/>
      </fig>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>ECG at 1-year follow-up shows stable LBBB and normal QT/QTc interval (405/432 msec).</p>
        </caption>
        <graphic xlink:href="2050-6511-14-8-5"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The occurrence of TdP in our patient after tosylchloramide ingestion can be explained considering that this compound acts as a strong oxidant of methionines and cysteines residues in proteins [<xref ref-type="bibr" rid="B7">7</xref>]. The activity of some of the ion channels regulating the duration of the QT interval is, indeed, strongly influenced by oxydation of critical methionine residues in channel proteins. In particular, voltage-dependent inactivation of Na<sub>V</sub> channels is significantly slowed down when methionine residues located in the so called IMF domain, which is responsible for voltage-dependent channel inactivation, are oxydized [<xref ref-type="bibr" rid="B8">8</xref>]. Consistently, tosylchloramide, which has a strong preference in oxydizing methionine residues [<xref ref-type="bibr" rid="B9">9</xref>], is one of the most powerful oxydants affecting Na<sub>V</sub> channel inactivation [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>] and it has been used as a pharmacological tool to abolish voltage-dependent inactivation in studies aiming to determine its contribution in the activity of specific cardiovascular drugs [<xref ref-type="bibr" rid="B11">11</xref>]. Tosylchloramide-induced slowing of Na<sub>V</sub> channel inactivation is a quite general phenomenon being observed in the brain, muscle and, importantly, cardiac isoform of these channels [<xref ref-type="bibr" rid="B8">8</xref>]. Oxydant-induced impairment of Na<sub>V</sub> voltage-dependent inactivation may <italic>per se</italic> explain the appearance of TdP in our patient intoxicated with tosylchloramide since it causes a marked increase in persistent I<sub>Na</sub> (I<sub>Na</sub>P ) [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], the inactivation-resistant Na<sup>+</sup> current which persists in the presence of prolonged membrane depolarization [<xref ref-type="bibr" rid="B14">14</xref>]. An increase in I<sub>Na</sub>P is, indeed, a well documented mechanism of QT prolongation and arrhythmogenesis and a potentailly relevant target for treatment and prevention of arrhythmias [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. In addition, an increase in I<sub>Na</sub>P is considered responsible for arrhythmogenesis in patients affected with the LQT3 syndrome which bear specific mutations in the Na<sub>V</sub>1.5 channel gene [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. Confirming the involvement of I<sub>Na</sub>P in oxydant-induced arrhythmogenesis, the I<sub>Na</sub>P blocker ranolazine was effective in preventing QT prolongation and early afterdepolarzations induced by the strong oxydant agent H<sub>2</sub>O<sub>2</sub> in cultured guinea pig cardiomyocytes [<xref ref-type="bibr" rid="B13">13</xref>]. Therefore, it is tempting to speculate that, in our patient, tosylchloramide exposure recapitulated the pathophysiological mechanism of cardiac arrhythmia in LQT3 patients.</p>
      <p>hERG is another oxydation-sensitive ion channel that could have been involved in the genesis of TdP in our patient. hERG is the main K<sup>+</sup> current responsible for rapid repolarization of cardiac myocytes in phase III of cardiac action potential [<xref ref-type="bibr" rid="B20">20</xref>] and its loss of function is one of the best characterized mechanisms of drug-induced or congenital LQT syndrome [<xref ref-type="bibr" rid="B21">21</xref>]. Specifically, mutations causing either loss of function or alterations in trafficking of hERG channels are responsible for the LQT2 syndrome [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>] whereas mutations in MiRP1, an accessory subunit that coassembles with hERG, have been found in LQT6 patients [<xref ref-type="bibr" rid="B24">24</xref>]. Intriguingly, by oxydizing critical methionine residues, tosylchloramide causes an almost complete loss of hERG channel activity <italic>in vitro</italic>[<xref ref-type="bibr" rid="B25">25</xref>] thus reproducing the effect of drugs or mutations known to cause TdP. Therefore, it is likely that hERG channel blockade could have played a role in the appearance of TdP in our patient.</p>
      <p>Finally, it is worth to remind that several oxydants, including tosylchloramide, may also increase the activity of L-type voltage-gated Ca<sup>2+</sup> channels (VGCC), even though, in this case, the specific inolvement of methionine residues has not been demonstrated [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. By increasing Ca<sup>2+</sup> influx through L-type VGCC, tosylchloramide is expected to prolong the plateau phase of cardiac action potential thus delaying cardiomyocyte repolarization and promoting the appearance of TdP. Intriguingly, an increase in L-type VGCC activity represents the mechanistic base of arrhythmias in LQT8 patients [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B30">30</xref>] bearing the Timothy syndrome mutations which cause an impairment in voltage-dependent Ca<sub>V</sub>1.2 channel inactivation [<xref ref-type="bibr" rid="B31">31</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>Oxidative stress has been proposed as one of the upstream events provoking clinical relevant arrhythmic responses [<xref ref-type="bibr" rid="B32">32</xref>] and several drugs used in therapy exert antiarrhythmic effects in part via their antioxidative property [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Here we suggest that severe arrhythmia may occur in the form of TdP after massive exposure to the oxidizing agent tosylchloramide. In fact, tosylchloramide has a pronounced impact on the activity of some of the ion channels regulating the QT interval. Since our patient exhibited no evidence of QT interval alteration after 12 and 24 months of follow-up, this strongly suggests a causal role of tosylchloramide intoxication for the ECG abnormalities occurred during observation in the ICU. Therefore, a strict electrocardiographic monitoring is advised in patients intoxicated with this compound.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient prior to publication of this case report and any accompanying images. A copy of the written consent is available for review by the Series Editor of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interest</title>
      <p>The authors declare that they have no competing interest.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>AM identified and managed the case; GPP and SA analyzed the data, conceived of the study and helped to draft the manuscript; VL, MM, AAN and IB performed the literature search and wrote the article. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; information</title>
      <p>Salvatore Amoroso and Gian Piero Perna equally contributed as senior authors.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/2050-6511/14/8/prepub">http://www.biomedcentral.com/2050-6511/14/8/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Blasco</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Joral</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fuente</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rodr&#xED;guez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garc&#xED;a</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dom&#xED;nguez</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Bronchial asthma due to sensitization to chloramine T</article-title>
          <source>J Investig Allergol Clin Immunol</source>
          <year>1992</year>
          <volume>2</volume>
          <fpage>167</fpage>
          <lpage>170</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kujala</surname>
            <given-names>VM</given-names>
          </name>
          <name>
            <surname>Reijula</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Ruotsalainen</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Heikkinen</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Occupational asthma due to chloramine-T solution</article-title>
          <source>Respir Med</source>
          <year>1995</year>
          <volume>89</volume>
          <fpage>693</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="doi">10.1016/0954-6111(95)90137-X</pub-id>
          <pub-id pub-id-type="pmid">8570884</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="book">
          <name>
            <surname>Grant</surname>
            <given-names>WM</given-names>
          </name>
          <source>Toxicology of the eye</source>
          <year>1974</year>
          <publisher-name>Charles C. Thomas, Srpingfield</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pascuzzi</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Storrow</surname>
            <given-names>AB</given-names>
          </name>
          <article-title>Mass casualties from acute inhalation of chloramine gas</article-title>
          <source>Mil Med</source>
          <year>1998</year>
          <volume>163</volume>
          <fpage>102</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">9503902</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gonzalez-Castro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holanda</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Canas</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Morlote</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Minambres</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Prieto Solis</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Myocardial damage after inhalation of chloramines</article-title>
          <source>Eur J Emerg Med</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>108</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1097/01.mej.0000188229.67980.c7</pub-id>
          <pub-id pub-id-type="pmid">16525243</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thygesen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Alpert</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>HD</given-names>
          </name>
          <article-title>Universal definition of myocardial infarction</article-title>
          <source>Eur Heart J</source>
          <year>2007</year>
          <volume>28</volume>
          <fpage>2525</fpage>
          <lpage>2538</lpage>
          <pub-id pub-id-type="pmid">17951287</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mihajlovic</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Cascone</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Biscoglio de Jim&#xE9;nez Bonino</surname>
            <given-names>MJ</given-names>
          </name>
          <article-title>Oxidation of methionine residues in equine growth hormone by Chloramine-T</article-title>
          <source>Int J Biochem</source>
          <year>1993</year>
          <volume>25</volume>
          <fpage>1189</fpage>
          <lpage>1193</lpage>
          <pub-id pub-id-type="doi">10.1016/0020-711X(93)90598-9</pub-id>
          <pub-id pub-id-type="pmid">8405661</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kassmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hansel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Leipold</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Birkenbeil</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>SQ</given-names>
          </name>
          <name>
            <surname>Hoshi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Heinemann</surname>
            <given-names>SH</given-names>
          </name>
          <article-title>Oxidation of multiple methionine residues impairs rapid sodium channel inactivation</article-title>
          <source>Pflugers Arch</source>
          <year>2008</year>
          <volume>456</volume>
          <fpage>1085</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="doi">10.1007/s00424-008-0477-6</pub-id>
          <pub-id pub-id-type="pmid">18369661</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>GK</given-names>
          </name>
          <article-title>Irreversible modification of sodium channel inactivation in toad myelinated nerve fibres by the oxidant chloramine-T</article-title>
          <source>J Physiol</source>
          <year>1984</year>
          <volume>346</volume>
          <fpage>127</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">6321714</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Qui&#xF1;onez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>DiFranco</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gonz&#xE1;lez</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Involvement of methionine residues in the fast inactivation mechanism of the sodium current from toad skeletal muscle fibers</article-title>
          <source>J Membr Biol</source>
          <year>1999</year>
          <volume>169</volume>
          <fpage>83</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1007/s002329900520</pub-id>
          <pub-id pub-id-type="pmid">10341030</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nawada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hisatome</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sasaki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ohtahara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kotake</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Mashiba</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Mechanism of inhibition of the sodium current by bepridil in guinea-pig isolated ventricular cells</article-title>
          <source>Br J Pharmacol</source>
          <year>1995</year>
          <volume>116</volume>
          <fpage>1775</fpage>
          <lpage>1780</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1476-5381.1995.tb16662.x</pub-id>
          <pub-id pub-id-type="pmid">8528559</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Niemann</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schmidtmayer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ulbricht</surname>
            <given-names>W</given-names>
          </name>
          <article-title>Chloramine-T effect on sodium conductance of neuroblastoma cells as studied by whole-cell clamp and single-channel analysis</article-title>
          <source>Pflugers Arch</source>
          <year>1991</year>
          <volume>418</volume>
          <fpage>129</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00370461</pub-id>
          <pub-id pub-id-type="pmid">1645860</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shryock</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maier</surname>
            <given-names>LS</given-names>
          </name>
          <name>
            <surname>Belardinelli</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2006</year>
          <volume>318</volume>
          <fpage>214</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.106.101832</pub-id>
          <pub-id pub-id-type="pmid">16565163</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maltsev</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Sabbah</surname>
            <given-names>HN</given-names>
          </name>
          <name>
            <surname>Higgins</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Silverman</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lesch</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Undrovinas</surname>
            <given-names>AI</given-names>
          </name>
          <article-title>Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes</article-title>
          <source>Circulation</source>
          <year>1998</year>
          <volume>98</volume>
          <fpage>2545</fpage>
          <lpage>2552</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.98.23.2545</pub-id>
          <pub-id pub-id-type="pmid">9843461</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hasenfuss</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Maier</surname>
            <given-names>LS</given-names>
          </name>
          <article-title>Mechanism of action of the new anti-ischemia drug ranolazine</article-title>
          <source>Clin Res Cardiol</source>
          <year>2008</year>
          <volume>97</volume>
          <fpage>222</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="doi">10.1007/s00392-007-0612-y</pub-id>
          <pub-id pub-id-type="pmid">18046526</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Undrovinas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maltsev</surname>
            <given-names>VA</given-names>
          </name>
          <article-title>Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart</article-title>
          <source>Cardiovasc Hematol Agents Med Chem</source>
          <year>2008</year>
          <volume>6</volume>
          <fpage>348</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.2174/187152508785909447</pub-id>
          <pub-id pub-id-type="pmid">18855648</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bennett</surname>
            <given-names>PB</given-names>
          </name>
          <name>
            <surname>Yazawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Makita</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>George</surname>
            <given-names>AL</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Molecular mechanism for an inherited cardiac arrhythmia</article-title>
          <source>Nature</source>
          <year>1995</year>
          <volume>376</volume>
          <fpage>683</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="doi">10.1038/376683a0</pub-id>
          <pub-id pub-id-type="pmid">7651517</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Christ&#xE9;</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chahine</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chevalier</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>P&#xE1;sek</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Changes in action potentials and intracellular ionic homeostasis in a ventricular cell model related to a persistent sodium current in SCN5A mutations underlying LQT3</article-title>
          <source>Prog Biophys Mol Biol</source>
          <year>2008</year>
          <volume>96</volume>
          <fpage>281</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2007.07.023</pub-id>
          <pub-id pub-id-type="pmid">17892895</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tian</surname>
            <given-names>XL</given-names>
          </name>
          <name>
            <surname>Yong</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Wan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Tchou</surname>
            <given-names>PJ</given-names>
          </name>
          <article-title>Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo</article-title>
          <source>Cardiovasc Res</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>256</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cardiores.2003.11.007</pub-id>
          <pub-id pub-id-type="pmid">14736542</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tseng</surname>
            <given-names>GN</given-names>
          </name>
          <article-title>I(Kr): the hERG channel</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>835</fpage>
          <lpage>849</lpage>
          <pub-id pub-id-type="doi">10.1006/jmcc.2000.1317</pub-id>
          <pub-id pub-id-type="pmid">11343409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sanguinetti</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>MT</given-names>
          </name>
          <article-title>A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel</article-title>
          <source>Cell</source>
          <year>1995</year>
          <volume>81</volume>
          <fpage>299</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(95)90340-2</pub-id>
          <pub-id pub-id-type="pmid">7736582</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Curran</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Splawski</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Timothy</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Vincent</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>MT</given-names>
          </name>
          <article-title>A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome</article-title>
          <source>Cell</source>
          <year>1995</year>
          <volume>80</volume>
          <fpage>795</fpage>
          <lpage>803</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(95)90358-5</pub-id>
          <pub-id pub-id-type="pmid">7889573</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chiang</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Roden</surname>
            <given-names>DM</given-names>
          </name>
          <article-title>The long QT syndromes: genetic basis and clinical implications</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2000</year>
          <volume>36</volume>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(00)00716-6</pub-id>
          <pub-id pub-id-type="pmid">10898405</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abbott</surname>
            <given-names>GW</given-names>
          </name>
          <name>
            <surname>Sesti</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Splawski</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Buck</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Lehmann</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Timothy</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Goldstein</surname>
            <given-names>SA</given-names>
          </name>
          <article-title>MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia</article-title>
          <source>Cell</source>
          <year>1999</year>
          <volume>97</volume>
          <fpage>175</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80728-X</pub-id>
          <pub-id pub-id-type="pmid">10219239</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Su</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Limberis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kolbe</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Heinemann</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Hoshi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>BF</given-names>
          </name>
          <name>
            <surname>Gintant</surname>
            <given-names>GA</given-names>
          </name>
          <article-title>Functional consequences of methionine oxidation of hERG potassium channels</article-title>
          <source>Biochem Pharmacol</source>
          <year>2007</year>
          <volume>74</volume>
          <fpage>702</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bcp.2007.06.002</pub-id>
          <pub-id pub-id-type="pmid">17624316</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Campbell</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Stamler</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Strauss</surname>
            <given-names>HC</given-names>
          </name>
          <article-title>Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols</article-title>
          <source>J Gen Physiol</source>
          <year>1996</year>
          <volume>108</volume>
          <fpage>277</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.1085/jgp.108.4.277</pub-id>
          <pub-id pub-id-type="pmid">8894977</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamaoka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yakehiro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fujii</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Seyama</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Effect of sulfhydryl reagents on the regulatory system of the L-type Ca channel in frog ventricular myocytes</article-title>
          <source>Pflugers Arch</source>
          <year>2000</year>
          <volume>440</volume>
          <fpage>207</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">10898520</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jacobs</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Knight</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>McDonald</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8)</article-title>
          <source>Hear Rhythm</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>967</fpage>
          <lpage>970</lpage>
          <pub-id pub-id-type="doi">10.1016/j.hrthm.2006.04.024</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Splawski</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Timothy</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Sharpe</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Decher</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bloise</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Napolitano</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Joseph</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Condouris</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tager-Flusberg</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Priori</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Sanguinetti</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>MT</given-names>
          </name>
          <article-title>Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title>
          <source>Cell</source>
          <year>2004</year>
          <volume>119</volume>
          <fpage>19</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2004.09.011</pub-id>
          <pub-id pub-id-type="pmid">15454078</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Splawski</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Timothy</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Decher</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sachse</surname>
            <given-names>FB</given-names>
          </name>
          <name>
            <surname>Beggs</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Sanguinetti</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>MT</given-names>
          </name>
          <article-title>Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>8089</fpage>
          <lpage>8096</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0502506102</pub-id>
          <pub-id pub-id-type="pmid">15863612</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Barrett</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Tsien</surname>
            <given-names>RW</given-names>
          </name>
          <article-title>The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2008</year>
          <volume>105</volume>
          <fpage>2157</fpage>
          <lpage>2162</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0710501105</pub-id>
          <pub-id pub-id-type="pmid">18250309</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jeong</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sturdy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Varghese</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Sovari</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Dudley</surname>
            <given-names>SC</given-names>
          </name>
          <article-title>Metabolic stress, reactive oxygen species, and arrhythmia</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>454</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.09.018</pub-id>
          <pub-id pub-id-type="pmid">21978629</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation</article-title>
          <source>Int J Cardiol</source>
          <year>2010</year>
          <volume>145</volume>
          <fpage>140</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2009.06.054</pub-id>
          <pub-id pub-id-type="pmid">19616323</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Naccarelli</surname>
            <given-names>GV</given-names>
          </name>
          <name>
            <surname>Lukas</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Carvedilol&#x2019;s antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction</article-title>
          <source>Clin Cardiol</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>165</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="doi">10.1002/clc.4960280403</pub-id>
          <pub-id pub-id-type="pmid">15869048</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
